A Systematic Review Comparing Mineral Trioxide Aggregate to Other Commercially Available Direct Pulp Capping Agents in Dogs

A Systematic Review Comparing Mineral Trioxide Aggregate to Other Commercially Available Direct Pulp Capping Agents in Dogs

Very important pulp remedy (VPT) and direct pulp capping (DPC) are procedures repeatedly carried out in canine for the administration of acute tooth fractures and as a part of administration for traumatic malocclusions. The aim of this assessment is to use an evidence-based medication strategy to systematically assessment and consider the scientific literature evaluating the efficacy of mineral trioxide mixture (MTA) to different commercially out there supplies used for VPT within the everlasting enamel of canine.
The 9 research assembly inclusion standards had been reviewed and every research proof was labeled utilizing a grading system modified from the Oxford Centre for Proof-Primarily based Medication. For the research assembly inclusion standards, MTA constantly carried out as effectively or higher than different commercially out there merchandise when it comes to calcific barrier formation and biocompatibility.
This assessment discovered a scarcity of consistency between the research making a direct comparability of the outcomes unreliable. Future research would profit from the implementation of a typical scoring system for histology, equal and longer research period occasions and the correlation of histological and radiographic information.

Molybdenum Trioxide Quantum Dot-Encapsulated Nanogels for Virus Detection by Floor-Enhanced Raman Scattering on a 2D Substrate

Using nanogels (NGs) to modulate surface-enhanced Raman scattering (SERS) actions is launched as an progressive technique to deal with sure important points with SERS-based immunoassays. This contains the chemical deformation of SERS nanotags, in addition to their nonspecific interactions and efficient “hotspots” formation.
Herein, the polymeric cocoon and stimuli-responsive properties of NGs had been used to encapsulate SERS nanotags containing plasmonic molybdenum trioxide quantum dots (MoO3-QDs). The pH-controlled launch of the encapsulated nanotags and their subsequent localization by maleimide-functionalized magnetic nanoparticles facilitated the creation of “hotspots” areas with catalyzed SERS actions. This strategy resulted in growing a biosensing platform for the ultrasensitive immunoassays of hepatitis E virus (HEV) or norovirus (NoV).
The immunoassays had been optimized utilizing the corresponding virus-like particles to realize limits of detection of 6.5 and eight.2 fg/mL for HEV-LPs and NoV-LPs, respectively. The SERS-based approach achieved a sign enhancement issue of as much as ∼108 as a result of mixed electromagnetic and chemical mechanisms of the employed dual-SERS substrate of MoO3-QDs/2D hexagonal boron nitride nanosheets.
The spotlight and validation of the developed SERS-based immunoassays was the detection of NoV in contaminated sufferers’ fecal specimen and medical HEV G7 subtype. Importantly, this method can be utilized to take care of the soundness of SERS nanotags and enhance their reliability in immunoassays.

Drilling into the Metabolomics to Improve Perception on Corn and Wheat Responses to Molybdenum Trioxide Nanoparticles

Metabolomics is an rising device to grasp the potential implications of nanotechnology, notably for agriculture. Though molybdenum (Mo) is a identified plant micronutrient, little is understood of its metabolic perturbations. Right here, corn and wheat seedlings had been uncovered to MoO3 nanoparticles (NPs) and the corresponding bioavailable Mo6+ ion at reasonable and extreme ranges by means of root exposures.
Physiologically, corn was extra delicate to Mo, which gathered as much as 3.63 occasions extra Mo than wheat. In distinction, metabolomics indicated 21 dysregulated metabolites in corn leaves and 53 in wheat leaves. 5 extra metabolomic pathways had been perturbed in wheat leaves in comparison with corn leaves. Along with the general metabolomics evaluation, we additionally analyzed particular person metabolite courses (e.g., amino acids, natural acids, and so forth.), yielding extra dysregulated metabolites in plant tissues: 7 for corn and seven for wheat.
Most of those had been amino acids in addition to some sugars. Further considerably dysregulated metabolites (e.g., asparagine, fructose, lowered glutathione, mannose) had been recognized in each corn and wheat, because of Mo NP publicity, by using particular person metabolite group evaluation. Focused metabolite evaluation of particular person teams is thus essential for locating extra important metabolites. We show the worth of metabolomics to check early stage plant responses to NP publicity.
A Systematic Review Comparing Mineral Trioxide Aggregate to Other Commercially Available Direct Pulp Capping Agents in Dogs

Arsenic trioxide enhances the chemotherapeutic effectivity of cisplatin in cholangiocarcinoma cells through inhibiting the 14-3-3ε-mediated survival mechanism

Cholangiocarcinoma (CCA) is the second most frequent main liver carcinoma with excessive levels of malignancy and mortality. Chemotherapy performs a key function within the therapy of CCA, nonetheless, the low chemotherapeutic effectivity results in a bottleneck. So unraveling the potential mechanisms to boost the effectivity (lowered the dosage and enhanced the results of chemotherapy medication) and figuring out different therapeutic methods in CCA are urgently wanted.
Right here, we discovered that, in CCA cells, when cisplatin (CDDP) displayed anti-tumor results, it activated 14-3-3ε concurrently, which in flip shaped a survival mechanism through the phosphorylation of phosphatidylinositol 3-kinase/protein kinase B (PI-3K/Akt). Nonetheless, low concentrations of arsenic trioxide (ATO) may disrupt such survival mechanism and enhanced the effectivity. For the molecular mechanisms, ATO attenuated 14-3-3ε at each transcriptional and post-transcriptional (ubiquitination degradation) ranges.
Such repressive impact blocked the activation of PI-3K/Akt, and its downstream anti-apoptotic elements, B-cell lymphoma 2 (Bcl-2), and survivin. Collectively, our current research revealed that the synergistic results of ATO and CDDP could possibly be a novel strategy for enhancing the effectivity, which supplies an progressive therapeutic imaginative and prescient for the therapy of CCA.

Extreme Wernicke encephalopathy and acute pancreatitis because of all-trans-retinoic acid and arsenic trioxide throughout therapy of acute promyelocytic leukaemia: a case report

A 55-year-old lady developed acute promyelocytic leukaemia throughout therapy with all-trans-retinoic acid and arsenic trioxide. Initially, she introduced with signs of epigastric ache, vomiting, and nausea, and he or she developed acute pancreatitis. She was handled with parenteral dietary supplementation for 20 days. Nonetheless, the affected person continued to develop refractory hyponatraemia, hypotension, and apathy.
Lastly, the affected person was recognized with Wernicke encephalopathy (WE) utilizing head magnetic resonance imaging. The affected person underwent high-dose intravenous thiamine administration, and her signs had been alleviated. WE is a uncommon opposed occasion throughout acute pancreatitis remedy. Acute pancreatitis that’s attributable to all-trans-retinoic acid and arsenic trioxide is a uncommon complication of acute promyelocytic leukaemia throughout chemotherapy.
Additional research is important to enhance our comprehension of the danger elements for issues in sufferers with acute promyelocytic leukaemia, contemplating that the related issues had been probably attributable to a number of etiological elements.

Rat Androgen Receptor (AR) ELISA Kit

DLR-AR-Ra-48T 48T
EUR 528
  • Should the Rat Androgen Receptor (AR) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Androgen Receptor (AR) in samples from tissue homogenates, cell lysates or other biological fluids.

Rat Androgen Receptor (AR) ELISA Kit

DLR-AR-Ra-96T 96T
EUR 690
  • Should the Rat Androgen Receptor (AR) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Androgen Receptor (AR) in samples from tissue homogenates, cell lysates or other biological fluids.

Human Androgen Receptor (AR) ELISA Kit

RDR-AR-Hu-48Tests 48 Tests
EUR 522

Human Androgen Receptor (AR) ELISA Kit

RDR-AR-Hu-96Tests 96 Tests
EUR 724

Mouse Androgen Receptor (AR) ELISA Kit

RDR-AR-Mu-48Tests 48 Tests
EUR 534

Mouse Androgen Receptor (AR) ELISA Kit

RDR-AR-Mu-96Tests 96 Tests
EUR 742

Rat Androgen Receptor (AR) ELISA Kit

RDR-AR-Ra-48Tests 48 Tests
EUR 558

Rat Androgen Receptor (AR) ELISA Kit

RDR-AR-Ra-96Tests 96 Tests
EUR 776

Human Androgen Receptor (AR) ELISA Kit

RD-AR-Hu-48Tests 48 Tests
EUR 500

Human Androgen Receptor (AR) ELISA Kit

RD-AR-Hu-96Tests 96 Tests
EUR 692

Mouse Androgen Receptor (AR) ELISA Kit

RD-AR-Mu-48Tests 48 Tests
EUR 511

Mouse Androgen Receptor (AR) ELISA Kit

RD-AR-Mu-96Tests 96 Tests
EUR 709

Rat Androgen Receptor (AR) ELISA Kit

RD-AR-Ra-48Tests 48 Tests
EUR 534

Rat Androgen Receptor (AR) ELISA Kit

RD-AR-Ra-96Tests 96 Tests
EUR 742

Molybdenum(VI) oxide, 99.9%

GX8007-100G 100 g
EUR 130

Molybdenum(VI) oxide, 99.9%

GX8007-1KG 1 kg
EUR 389

Molybdenum(VI) oxide, 99.9%

GX8007-250G 250 g
EUR 183

Ar/ Rat Ar ELISA Kit

ELI-04146r 96 Tests
EUR 886

Molybdenum Cofactor Sulfurase (MOCOS) Antibody

20-abx113870
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 Protein

20-abx263321
  • EUR 1609.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 2 µg
  • Shipped within 5-10 working days.

Molybdenum Cofactor Sulfurase (MOCOS) Antibody

abx235263-100ug 100 ug
EUR 481
  • Shipped within 5-12 working days.

AR Antibody

32572-100ul 100ul
EUR 252

AR antibody

10R-2031 100 ul
EUR 403
Description: Mouse monoclonal AR antibody

AR Antibody

1-CSB-PA006094
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against AR. Recognizes AR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

AR Antibody

CSB-PA001975KA01HU-
EUR 335
  • Form: liquid
  • Buffer: Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. Affinity purification
Description: A polyclonal antibody against AR. Recognizes AR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, ICC;WB:1:500-1:1000, IHC:1:50-1:100, ICC:1:50-1:100

AR Antibody

CSB-PA001975KA01HU-100ul 100ul
EUR 389
  • Form: liquid
  • Buffer: Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3. Affinity purification
Description: A polyclonal antibody against AR. Recognizes AR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, ICC;WB:1:500-1:1000, IHC:1:50-1:100, ICC:1:50-1:100

AR Antibody

1-CSB-PA056943
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
Description: A polyclonal antibody against AR. Recognizes AR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100

AR Antibody

1-CSB-PA05979A0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against AR. Recognizes AR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

AR 231453

B3269-10 10 mg
EUR 245
Description: AR 231453 is an agonist of GPR119 with EC50 value of 0.68nM [1].AR 231453 is the first subnanomolar agonist of GPR119. It is highly selective against GPR119 over a 76 receptor and enzyme profiling panel (CEREP) including the known incretin receptors.

AR 231453

B3269-5 5 mg
EUR 179
Description: AR 231453 is an agonist of GPR119 with EC50 value of 0.68nM [1].AR 231453 is the first subnanomolar agonist of GPR119. It is highly selective against GPR119 over a 76 receptor and enzyme profiling panel (CEREP) including the known incretin receptors.

AR 231453

B3269-5.1 10 mM (in 1mL DMSO)
EUR 195
Description: AR 231453 is an agonist of GPR119 with EC50 value of 0.68nM [1].AR 231453 is the first subnanomolar agonist of GPR119. It is highly selective against GPR119 over a 76 receptor and enzyme profiling panel (CEREP) including the known incretin receptors.

AR Antibody

DF6783 200ul
EUR 304
Description: AR Antibody detects endogenous levels of total AR.

AR antibody

70R-35838 100 ug
EUR 327
Description: Rabbit polyclonal AR antibody

AR A014418

20-abx076761
  • EUR 718.00
  • EUR 314.00
  • 25 mg
  • 5 mg
  • Shipped within 5-12 working days.

AR Antibody

BF0418 200ul
EUR 376
Description: AR antibody detects endogenous levels of total AR.

AR Antibody

1-CSB-PA011255
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against AR. Recognizes AR from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000

AR Antibody

1-CSB-PA011256
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against AR. Recognizes AR from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

AR Antibody

1-CSB-PA011257
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against AR. Recognizes AR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, IF, ELISA;IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

AR Antibody

1-CSB-PA011258
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against AR. Recognizes AR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

AR siRNA

20-abx900461
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol
  • Shipped within 5-10 working days.

AR siRNA

20-abx908237
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol
  • Shipped within 5-10 working days.

AR siRNA

20-abx908238
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol
  • Shipped within 5-10 working days.

AR Antibody

ABD6783 100 ug
EUR 438

AR-A014418

A3184-10 10 mg
EUR 128
Description: IC50: 104 ± 27 nMGlycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer?s disease (AD). AR-A014418 is a selective GSK-3 inhibitor.

AR-A014418

A3184-5.1 10 mM (in 1mL DMSO)
EUR 123
Description: IC50: 104 ± 27 nMGlycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer?s disease (AD). AR-A014418 is a selective GSK-3 inhibitor.

AR-A014418

A3184-50 50 mg
EUR 268
Description: IC50: 104 ± 27 nMGlycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer?s disease (AD). AR-A014418 is a selective GSK-3 inhibitor.

AR-A014418

A3184-S Evaluation Sample
EUR 81
Description: IC50: 104 ± 27 nMGlycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer?s disease (AD). AR-A014418 is a selective GSK-3 inhibitor.

AR-C155858

A3185-10 10 mg
EUR 991
Description: AR-C155858 is a potent and selective inhibitor of monocarboxylate transporters MCT1 and MCT2 with Ki values of 2.3nM and less than 10 nM, respectively [1].MCT is a monocarboxylate transporter family with 14 members.

AR-C155858

A3185-5 5 mg
EUR 611
Description: AR-C155858 is a potent and selective inhibitor of monocarboxylate transporters MCT1 and MCT2 with Ki values of 2.3nM and less than 10 nM, respectively [1].MCT is a monocarboxylate transporter family with 14 members.

AR-C155858

A3185-50 50 mg
EUR 2800
Description: AR-C155858 is a potent and selective inhibitor of monocarboxylate transporters MCT1 and MCT2 with Ki values of 2.3nM and less than 10 nM, respectively [1].MCT is a monocarboxylate transporter family with 14 members.

AR-C155858

HY-13248 10mM/1mL
EUR 483

AR 231453

HY-15564 10mM/1mL
EUR 160

AR-A014418

HY-10512 50mg
EUR 342

AR-9281

HY-111151 5mg
EUR 211

AR-08

HY-U00371 20mg
EUR 13439

pCDNA3.1-AR

PVT18102 2 ug
EUR 300

Clematichinenoside AR

TBW00371 10mg
EUR 847

ar-Tumerone

TBW01373 5mg Ask for price

AR-C155858

B2743-1 1 mg
EUR 348

KAF/AR/ Rat KAF/ AR ELISA Kit

ELA-E0006r 96 Tests
EUR 886

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx005887
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx113871
  • EUR 732.00
  • EUR 398.00
  • 150 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx036894-100ug 100 ug
EUR 391
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx037731-100ug 100 ug
EUR 391
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131326
  • EUR 439.00
  • EUR 133.00
  • EUR 1233.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131327
  • EUR 425.00
  • EUR 133.00
  • EUR 1205.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx135733
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321401
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321402
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx235264-100ug 100 ug
EUR 481
  • Shipped within 5-12 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx321947
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx322547
  • EUR 439.00
  • EUR 328.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx304514
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Hu01
  • EUR 503.20
  • EUR 238.00
  • EUR 1612.00
  • EUR 604.00
  • EUR 1108.00
  • EUR 400.00
  • EUR 3880.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Q9NZB8
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 21.5kDa
  • Isoelectric Point: Inquire
Description: Recombinant Human Molybdenum Cofactor Synthesis 1 expressed in: E.coli

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Mu01
  • EUR 458.40
  • EUR 226.00
  • EUR 1444.00
  • EUR 548.00
  • EUR 996.00
  • EUR 370.00
  • EUR 3460.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Q5RKZ7
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 22.4kDa
  • Isoelectric Point: Inquire
Description: Recombinant Mouse Molybdenum Cofactor Synthesis 1 expressed in: E.coli

Beta3-AR Antibody

3939-200
EUR 354

Beta3-AR Antibody

3939-30T
EUR 146

AR Polyclonal Antibody

41904-100ul 100ul
EUR 252

AR Polyclonal Antibody

41904-50ul 50ul
EUR 187

AR-beta3 Antibody

44295-100ul 100ul
EUR 252

AR-beta3 Antibody

44295-50ul 50ul
EUR 187

AR Polyclonal Antibody

40609-100ul 100ul
EUR 252

AR Polyclonal Antibody

40609-50ul 50ul
EUR 187

AR Polyclonal Antibody

40610-100ul 100ul
EUR 252

AR Polyclonal Antibody

40610-50ul 50ul
EUR 187

AR-M 1896

B5328-1 1 mg
EUR 486
Description: Binding IC50: 1.76 nM for rGalR2; 879 nM for hGalR1Galanin is a 29-aa neuropeptide with a complex role in pain processing. Galanin receptor subtypes are present in dorsal root ganglia and spinal cord with a differential distribution.

AR-C 102222

B5504-10 10 mg
EUR 421

AR-C 102222

B5504-50 50 mg
EUR 1617

AR Blocking Peptide

DF6783-BP 1mg
EUR 195

AR-42J cells

C0018004 One Frozen vial
EUR 455

AR Conjugated Antibody

C32572 100ul
EUR 397

Netarsudil (AR-13324)

B7807-2 2 mg
EUR 305
Description: Ki: 0.43141.3 nMNetarsudil (AR-13324) is a ROCK inhibitor.The Rho kinases are serine/threonine protein kinases existing as 2 isoforms, ROCK1 and ROCK2, which are widely expressed in various tissues, such as the trabecular meshwork.
A greater understanding of those threat elements could assist to enhance the prognosis of sufferers with acute promyelocytic leukaemia at an early stage.

Leave a Reply

Your email address will not be published. Required fields are marked *